Real-world efficacy, safety and clinical outcomes of ombitasvir/ paritaprevir/ ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: Turkey experienc

AYGEN B., DEMİRTÜRK N., YILDIZ O., ÇELEN M. K., ÇELİK İ., BARUT H. Ş., ...More

AASLD - TASL CONNECT REGIONAL MEETING, İstanbul, Turkey, 15 - 16 March 2019, (Full Text)

  • Publication Type: Conference Paper / Full Text
  • City: İstanbul
  • Country: Turkey
  • Erciyes University Affiliated: Yes